Literature DB >> 3981419

Factors affecting the measurement of lidocaine protein binding by equilibrium dialysis in human serum.

K V Ponganis, D R Stanski.   

Abstract

A systematic study was undertaken to assess in vitro factors that influence the value of the lidocaine free fraction obtained by equilibrium dialysis in human serum. These factors include pH readjustment to 7.40 after serum storage; choice of buffers for dialysis; the effect of phosphate buffer ionic strength; temperature of storage for serum samples; the use of untreated versus silanized glassware for storage; and age of serum. It was concluded that the pH of serum that contains lidocaine must be brought back to the original whole blood pH found in the patient before equilibrium dialysis because the protein binding of lidocaine is critically dependent on pH. It was also found that Krebs-Ringer bicarbonate buffer, when used with room air atmosphere in the dialysis cell, is not adequate to control pH even when serum pH is readjusted to the physiological pH of the patient. Isotonic phosphate buffer and 0.10 M phosphate buffer are effective for pH control and give identical values of lidocaine free fraction when the original serum sample is first pH-adjusted. If the pH of the serum is correct and the pH of the buffer remains constant, then freezing, the choice of container, or the age of serum are not important variables affecting the measurement of the lidocaine free fraction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981419     DOI: 10.1002/jps.2600740115

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Age does not influence the serum protein binding of bupivacaine.

Authors:  B T Veering; A G Burm; M P Gladines; J Spierdijk
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

2.  Effect of sertraline on protein binding of warfarin.

Authors:  G Apseloff; K D Wilner; N Gerber; L M Tremaine
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

3.  Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health.

Authors:  Karli R Reiding; L Renee Ruhaak; Hae-Won Uh; Said El Bouhaddani; Erik B van den Akker; Rosina Plomp; Liam A McDonnell; Jeanine J Houwing-Duistermaat; P Eline Slagboom; Marian Beekman; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2016-12-08       Impact factor: 5.911

Review 4.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

Review 5.  Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.

Authors:  Sherri A Smith; Nigel J Waters
Journal:  Pharm Res       Date:  2018-12-28       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.